IRIS
NOVI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.001
Totale 2.001
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.001
Totale 2.001
Salva come PNG Salva come JPEG
Città #
Genova 1.177
Genoa 402
Rapallo 329
Vado Ligure 89
Bordighera 4
Totale 2.001
Salva come PNG Salva come JPEG
Nome #
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register 135
Different MRI patterns in MS worsening after stopping fingolimod 132
The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms 120
Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS 116
Dramatic rebounds of MS during pregnancy following fingolimod withdrawal. 113
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 108
Tocilizumab in MOG-antibody spectrum disorder: a case report 103
Ghost spasticity in multiple sclerosis 99
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 96
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 94
Acute disseminated encephalomyelitis after SARS-CoV-2 infection 93
Longitudinal brain magnetic resonance imaging and real-time quaking induced conversion analysis in presymptomatic Creutzfeldt-Jakob disease 88
Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system. 84
Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS 82
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study 68
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population 62
Assessing upper limb function in Multiple Sclerosis by an engineered glove 61
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? 52
Fulminant Hepatitis Associated with Echovirus 25 during Treatment with Ocrelizumab for Multiple Sclerosis 48
Interleukin-6 Receptor Blockade in Treatment- Refractory MOG-Ab–Associated Disease and Neuromyelitis Optica Spectrum Disorders 47
Tailoring B cell depletion therapy in MS according to memory B cell monitoring 45
Erythropoietin therapy in a case of neonatal anemia after exposure to natalizumab throughout pregnancy 44
Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies 42
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis 37
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis 36
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? 30
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS 27
Vaccinations in patients with multiple sclerosis: a real-world, single-center experience 15
Relapsing meningitis and limbic encephalitis in anti-AQP4-Ab-associated neuromyelitis optica spectrum disorder 3
Totale 2.080
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.065
article - articoli 8.815
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.880
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020457 0 0 0 39 46 73 64 43 65 74 41 12
2020/2021279 18 16 22 53 37 15 19 21 18 31 16 13
2021/2022297 11 7 12 24 17 20 12 67 16 38 29 44
2022/2023396 38 38 8 48 42 63 2 23 66 4 57 7
2023/2024315 14 26 3 36 20 68 57 13 16 18 10 34
2024/2025128 59 49 18 2 0 0 0 0 0 0 0 0
Totale 2.080